STATEMENT 2021

• Simple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from Ferring

By caju in STATEMENT 2021 on 16 February 2021

By divesting its rights to Simple Pharma on this transaction, Ferring is able to focus on areas of high unmet need to bring the most value to patients and healthcare professionals. Testavan® (transdermal testosterone gel 2%) is a testosterone…

• “Standing together against injustice” – a message from Per Falk, President and Chief Science Officer at Ferring

By pulse in STATEMENT 2021 on 11 June 2020

“Standing together against injustice” – a message from Per Falk, President and…

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.